NationalCovishield And Covaxin Get Regular Market Approval For Use In Adult PopulationBY Outlook Web Desk
NationalNEWSFLASH: Govt Expert Panel Recommends Regular Market Approval For Covishield And CovaxinBY Outlook Web Desk
miscellaneousMix & Match Of Covaxin, Covishield Elicits 4 Times Antibody Response, Says StudyBY Outlook Web Desk
miscellaneousCentre should allow vaccination of children in 12-15 age group: Maha health ministerBY Outlook Web Desk
miscellaneousNeed to hold vaccination on war footing, says MP CM Chouhan as inoculation drive for children beginsBY Outlook Web Desk
NationalHealth Minister Mandaviya Instructs States To Avoid Mixing Up Of Covid Vaccines For ChildrenBY Outlook Web Desk
NationalOnly Covaxin To Be Administered To Children, Registrations On CoWIN From January 1, Health MinistryBY Outlook Web Desk
NationalCovid-19 Vaccine For Teenagers: DCGI Grants Emergency Authorisation To CovaxinBY Outlook Web Desk
BusinessThe Jab Of Life: Covaxin’s Success Proves Bharat Biotech Was On Right PathBY Outlook Web Desk
miscellaneousSecond COVID-19 Vaccine Dose Of 18 Lakh People Overdue In West BengalBY Outlook Web Desk
Making A DifferenceUK To Add Covaxin To List Of Approved Covid-19 Vaccines For International TravellersBY Outlook Web Desk
Making A DifferenceUS To Allow Vaccinated Foreigners To Enter From Nov 8: What It Means For Indian TravellersBY Outlook Web Desk
NationalCovaxin Gets WHO Nod For Emergency Use: What That Means For Indian TravelersBY Outlook Web Desk
NationalCovaxin: WHO Panel Recommends Emergency Use Listing Status For Bharat Biotech's Covid VaccineBY Outlook Web Desk
